Kubota Pharmaceutical HoldingsKubota Pharmaceutical Holdings Co., Ltd.4596東証グロース医薬品FY ending Dec 2023, consolidated, IFRS

Kubota Pharmaceutical Holdings FY ending Dec 2023 results

Kubota Pharmaceutical Holdings brought in ¥39.9M in revenue.

Revenue changed +383.2% from the prior year.

What changed from last year

FY ending Dec 2022 → FY ending Dec 2023

FY ending Dec 2022 → FY ending Dec 2023

※ Cost of revenue is not disclosed; expenses are combined

※ Operating income is not disclosed; the chart goes straight to pretax income including investment gains

A machine-readable operating income value exists, but it is not in the validated published data, so the chart is omitted.

Show source documents (5)

EDINET (FSA Japan)
有価証券報告書－第11期(2025/01/01－2025/12/31)
ID S100XUHX2026-03-27Open
EDINET (FSA Japan)
有価証券報告書－第10期(2024/01/01－2024/12/31)
ID S100VISG2025-03-28Open
EDINET (FSA Japan)
有価証券報告書－第8期(2022/01/01－2022/12/31)
ID S100QHRB2023-03-29Open
EDINET (FSA Japan)
有価証券報告書－第7期(令和3年1月1日－令和3年12月31日)
ID S100NRX42022-03-29Open
EDINET (FSA Japan)
有価証券報告書－第6期(令和2年1月1日－令和2年12月31日)
ID S100L2EY2021-03-29Open

Extracted from XBRL: 10 / Derived from other figures: 1

Spotted an error? Report it (corrections keep the original record)

Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.